Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine …
AT Porter, AJB McEwan, JE Powe, R Reid… - International Journal of …, 1993 - Elsevier
Purpose: A large proportion of the practice of radiotherapy in the management of metastatic
adenocarcinoma of the prostate is associated with palliation of pain from osseous
metastases and improving quality of life. Radiation therapy is well known to be effective in
treating painful sites and may also be effective in reducing the propensity for adjuvantly
treated disease to become symptomatic. Strontium-89 is a systemic radionuclide that has
clinical efficacy in the palliation of pain from bony metastases. Methods and Materials: The …
adenocarcinoma of the prostate is associated with palliation of pain from osseous
metastases and improving quality of life. Radiation therapy is well known to be effective in
treating painful sites and may also be effective in reducing the propensity for adjuvantly
treated disease to become symptomatic. Strontium-89 is a systemic radionuclide that has
clinical efficacy in the palliation of pain from bony metastases. Methods and Materials: The …